Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint, Marco Maruzzo, Roberto Iacovelli, Martin Pichler, Jindřich Kopecký, Jakub Kucharz, Mimma Rizzo, Luca Galli, Thomas Büttner, Ugo De Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique Grande, Paolo Andrea Zucali, Ray Manneh Kopp, Giuseppe Fornarini, María T. Bourlon, Sarah Scagliarini, Javier Molina‐Cerrillo, Gaetano Aurilio, Marc Matrana, Renate Pichler, Carlo Cattrini, Tomáš Büchler, Francesco Massari, Emmanuel Seront, Fabio Calabrò, Álvaro Pinto, Rossana Berardi, Anca Zgură, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Aristotelis Bamias, Orazio Caffo, Giuseppe Procopio, Kaisa Sunela, Maria Bassanelli, Cinzia Ortega, Francesco Grillone, Johannes Landmesser, Michele Stanislaw Milella, Carlo Messina, Zsófia Kürönya, Alessandra Mosca, Dipen Bhuva, Daniele Santini, Nuno Vau, Franco Morelli, Lorena Incorvaia, Sara Elena Rebuzzi, Giandomenico Roviello, Andrey Soares, Renato Bisonni, Davide Bimbatti, Ignacio Ortego Zabalza, Alessandro Rizzo, Veronica Mollica, Giulia Sorgentoni, Fernando Sabino Marques Monteiro, Nicola Battelli, Sergio Bracarda, Camillo Porta